Heart failure & cardiomyopathies
Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study
Main finding · VAD or transplant; deathResult — go to the resultAdjusted hazard ratio 0.45 95% CI 0.23–0.85Authors' conclusion
Among patients receiving care by advanced HF cardiologists at VAD centers, there is less utilization of VAD and transplant for Black patients even after adjusting for HF severity, quality of life, and social determinants of health, despite similar care preferences.
Study context
- Population
- Ambulatory chronic systolic heart failure (HF) patients with high-risk features and no contraindication to ventricular assist device (VAD) at 21 VAD centres
- Participants
- 377 patients21 VAD centres
- Exposure
- Black vs White race
- Blackn = 100
- Outcome
- (1) VAD/transplant and (2) death
- Follow-up
- 2 years
Methodological detailsmulticentre, competing events cause-specific proportional hazards, multiple imputation
- Multicentre
- Competing events cause-specific proportional hazards
- Multiple imputation
Main finding
VAD or transplant; death
Adjusted hazard ratio
0.45
95% CI 0.23–0.85
By group
Black
- VAD or transplant
- 11 (11%)
- Death
- 18 (18%)
White
- VAD or transplant
- 62 (22%)
- Death
- 36 (13%)
VAD or transplant
Black11 (11%)
White62 (22%)
Death
Black18 (18%)
White36 (13%)
Blackvs White
adjusted HR 0.45 (95% CI 0.23–0.85)
As reported in the abstract
Observational data: associations, not effects.
Further findings
Preferences for VAD or life-sustaining therapies
- Similar by race; did not explain racial disparities
Original publication
Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study. Circ Heart Fail. Published 19 October 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →